Evidence Review

ApoB Testing

Verdict
Proven
Evidence Tier
A
Strong evidence
Human Studies
Yes — epidemiological
Typical Cost
$20/test
Apolipoprotein B (ApoB) is a single blood test that predicts cardiovascular risk better than standard lipid panels. It counts the actual number of atherogenic particles rather than estimating cholesterol content. Multiple studies show ApoB is superior to LDL-C for risk stratification. At roughly $20, it costs a fraction of the $400+ advanced panels marketed in longevity circles.

The full evidence review — including the $20 blood test that outperforms any $400 longevity panel for predicting cardiovascular risk — is in Section 1 (The Things That Actually Work) of The Anti-Longevity Playbook.

Reviewed by Dr. Ramy Khalil, MD · Double Board-Certified Internal Medicine · Last updated March 2026

Is ApoB testing worth it?

ApoB is a ~$20 blood test that predicts cardiovascular risk better than standard lipid panels. It measures atherogenic particle count directly, outperforming LDL-C for risk stratification.

Free Chapter

Want the full picture?
Start with a free chapter.

Read the first chapter of The Anti-Longevity Playbook free — including the intervention with stronger mortality data than ApoB Testing.

No spam. Just the free chapter.

More from The Things That Actually Work